Riskpilot← Back to searchSign inGet full accessFamwan AB
ABActiveOrg 5591364947Norbyvägen 46 A Lgh A1203Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 20170 employees
Revenue 2024
SEK 0
EBITDA margin
—
+5% vs 2023
Equity ratio
62.8%
Financial strength
Net profit 2024
SEK 3,6M
-34% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -33K | +5% |
| Net profit | SEK 3,6M | -34% |
| Total assets | SEK 14,1M | +17% |
| Equity | SEK 8,8M | +19% |
| Employees | 0 | — |
Legal name
Famwan AB
Org number
5591364947
Legal form
Aktiebolag
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
30 november 2017
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget ska bedriva medicinsk verksamhet med fokus på mobil provtagning. Bolaget skall även äga och bedriva förvaltning av aktier i dotter och intressebolag samt även arbeta med konsultationer inom företagsledning till dotter- och intressebolag samt till utomstående bolag samt därmed förenlig verksamhet.
Address
Norbyvägen 46 A Lgh A1203
Email
cecilia.waneus@encia.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 092 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 2 110 | −35 | −21 | −35 | −33 |
| Depreciation & amort. | −0 | −0 | — | −0 | — |
| EBIT | 2 110 | −35 | −21 | −35 | −33 |
| Net financials | — | — | −1 | 160 | 152 |
| Profit before tax | 1 584 | 1 | 2 609 | 6 919 | 4 565 |
| Tax | −338 | −1 | −539 | −1 425 | −960 |
| Net profit | 1 246 | 0 | 2 070 | 5 494 | 3 605 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 560 | 1 904 | 4 437 | 12 030 | 14 055 |
| Equity | 1 357 | 1 057 | 2 527 | 7 422 | 8 827 |
| Long-term debt | 0 | 0 | — | 0 | — |
| Short-term debt | 677 | 357 | 550 | 944 | 11 |
| Total debt | 677 | 357 | 550 | 944 | 11 |
EBITDA margin
-3336200.0%
This company
15.8%
Market median
-21115290% vs market
20202024
Equity ratio
62.8%
This company
38.2%
Market median
+64% vs market
20202024
Return on equity
40.8%
This company
18.4%
Market median
+122% vs market
20202024
Net profit margin
360488400.0%
This company
8.1%
Market median
+4450473974% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.59×
This company
0.62×
Market median
+5% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
HC Chief Executive Officer | Chief Executive Officer | 2022 |
AG | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Famwan AB 
Encia ABBoard members of Famwan AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Helena Cecilia Wänéus | Chief Executive Officer | 0 companies |
| Alf Gunnar Rune Sjödelius | Audit | 0 companies |
| Henrik Olof Bertil Wänéus | Chairman | 0 companies |
| Ludwig Olof Henriksson Wänéus | Board of Directors | 0 companies |